Zhongcheng Mo

3.3k total citations · 1 hit paper
65 papers, 2.4k citations indexed

About

Zhongcheng Mo is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Zhongcheng Mo has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 27 papers in Surgery and 15 papers in Immunology. Recurrent topics in Zhongcheng Mo's work include Cholesterol and Lipid Metabolism (24 papers), Reproductive Biology and Fertility (9 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). Zhongcheng Mo is often cited by papers focused on Cholesterol and Lipid Metabolism (24 papers), Reproductive Biology and Fertility (9 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). Zhongcheng Mo collaborates with scholars based in China, Canada and United States. Zhongcheng Mo's co-authors include Yuanjie Xie, Shuang-lian Long, Xin Zeng, Yating Liu, Shengsong Tang, Qian Ning, Chao‐Ke Tang, Wenjie Feng, Ji Xiao and Kun Ren and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Zhongcheng Mo

63 papers receiving 2.4k citations

Hit Papers

Polycystic ovarian syndrome: Correlation between hyperand... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongcheng Mo China 29 899 645 496 463 458 65 2.4k
Masoud Darabi Iran 24 617 0.7× 240 0.4× 284 0.6× 267 0.6× 177 0.4× 108 1.8k
Yanzhi Du China 30 1.3k 1.4× 675 1.0× 371 0.7× 109 0.2× 364 0.8× 90 2.6k
Yue Jiang China 26 886 1.0× 433 0.7× 706 1.4× 78 0.2× 679 1.5× 86 2.0k
Bin Wu China 23 813 0.9× 210 0.3× 377 0.8× 271 0.6× 168 0.4× 108 1.7k
Daniela Marzioni Italy 33 935 1.0× 147 0.2× 275 0.6× 175 0.4× 434 0.9× 92 2.4k
Jing Yang China 26 741 0.8× 555 0.9× 453 0.9× 88 0.2× 835 1.8× 150 2.3k
Dan Zhao China 28 1.2k 1.3× 125 0.2× 566 1.1× 124 0.3× 391 0.9× 118 2.3k
Kirsi Narko Finland 16 1.0k 1.1× 99 0.2× 443 0.9× 391 0.8× 283 0.6× 22 2.8k
Salama A. Salama United States 29 848 0.9× 400 0.6× 496 1.0× 131 0.3× 133 0.3× 68 1.9k
Luciana Bordin Italy 26 643 0.7× 539 0.8× 111 0.2× 137 0.3× 199 0.4× 84 1.9k

Countries citing papers authored by Zhongcheng Mo

Since Specialization
Citations

This map shows the geographic impact of Zhongcheng Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongcheng Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongcheng Mo more than expected).

Fields of papers citing papers by Zhongcheng Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongcheng Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongcheng Mo. The network helps show where Zhongcheng Mo may publish in the future.

Co-authorship network of co-authors of Zhongcheng Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongcheng Mo. A scholar is included among the top collaborators of Zhongcheng Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongcheng Mo. Zhongcheng Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Yixin, et al.. (2025). Midkine Promote Atherosclerosis by Regulating the Expression of ATP-Binding Cassette Transporter A1 via Activator Protein-1. Cardiovascular Drugs and Therapy. 40(2). 435–446.
2.
Zeng, Xin, Qiaoqing Zhong, Ming Li, et al.. (2023). Androgen increases klotho expression via the androgen receptor-mediated pathway to induce GCs apoptosis. Journal of Ovarian Research. 16(1). 10–10. 12 indexed citations
3.
Chen, Zhuo, et al.. (2021). Dietary Interventions: A Promising Treatment for Polycystic Ovary Syndrome. Annals of Nutrition and Metabolism. 77(6). 313–323. 55 indexed citations
4.
Ning, Qian, et al.. (2020). Progress on the role of extrachromosomal DNA in tumor pathogenesis and evolution. Clinical Genetics. 99(4). 503–512. 9 indexed citations
5.
Deng, Chunyan, et al.. (2020). The Role of the PI3K/AKT/mTOR Signalling Pathway in Male Reproduction. Current Molecular Medicine. 21(7). 539–548. 58 indexed citations
6.
Zeng, Xin, et al.. (2020). Mitochondrial Dysfunction in Polycystic Ovary Syndrome. DNA and Cell Biology. 39(8). 1401–1409. 38 indexed citations
7.
Tang, Sha, et al.. (2020). Mechanisms of immune escape in the cancer immune cycle. International Immunopharmacology. 86. 106700–106700. 122 indexed citations
8.
Mo, Zhongcheng, et al.. (2020). Emerging role of Insig-1 in lipid metabolism and lipid disorders. Clinica Chimica Acta. 508. 206–212. 30 indexed citations
9.
Long, Shuang-lian, et al.. (2020). The role of advanced glycation end products in human infertility. Life Sciences. 255. 117830–117830. 26 indexed citations
10.
Chen, Zhuo, et al.. (2019). Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome. DNA and Cell Biology. 38(8). 754–762. 35 indexed citations
11.
Tang, Yixin, et al.. (2019). p22phox promotes Ang-II-induced vascular smooth muscle cell phenotypic switch by regulating KLF4 expression. Biochemical and Biophysical Research Communications. 514(1). 280–286. 14 indexed citations
12.
Zeng, Xin, Yuanjie Xie, Yating Liu, Shuang-lian Long, & Zhongcheng Mo. (2019). Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clinica Chimica Acta. 502. 214–221. 328 indexed citations breakdown →
14.
Long, Shuang-lian, Yukun Li, Yuanjie Xie, et al.. (2017). Neurite Outgrowth Inhibitor B Receptor: A Versatile Receptor with Multiple Functions and Actions. DNA and Cell Biology. 36(12). 1142–1150. 17 indexed citations
15.
Mo, Zhongcheng, et al.. (2016). A high-density lipoprotein-mediated drug delivery system. Advanced Drug Delivery Reviews. 106(Pt A). 132–147. 61 indexed citations
16.
Huang, Zhuping, et al.. (2016). The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis. Cardiovascular Toxicology. 17(1). 1–12. 45 indexed citations
17.
Lv, Yun-Cheng, Yanyan Tang, Ping Zhang, et al.. (2016). Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis. PLoS ONE. 11(6). e0157265–e0157265. 65 indexed citations
18.
Yu, Xiaohua, Xiaoxu Li, Guojun Zhao, et al.. (2012). OxLDL up-regulates Niemann–Pick type C1 expression through ERK1/2/COX-2/PPARα-signaling pathway in macrophages. Acta Biochimica et Biophysica Sinica. 44(2). 119–128. 17 indexed citations
19.
Yin, Kai, Zhongcheng Mo, Guojun Zhao, et al.. (2011). Tristetraprolin-dependent Post-transcriptional Regulation of Inflammatory Cytokine mRNA Expression by Apolipoprotein A-I. Journal of Biological Chemistry. 286(16). 13834–13845. 48 indexed citations
20.
Xiao, Ji, Xiehong Liu, Meimei Liu, et al.. (2010). Ibrolipim increases ABCA1/G1 expression by the LXRα signaling pathway in THP-1 macrophage-derived foam cells. Acta Pharmacologica Sinica. 31(10). 1343–1349. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026